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ORIGINAL ARTICLE
Effect of temperature on storage of ethionamide during susceptibility 
testing
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ABSTRACT
Objective: Ethionamide being thermolabile in nature, effect of temperature on the drug and its stability in liquid and 
solid media during susceptibility testing procedures was assessed to understand the inconsistency in DST formats. 
Methods: Working solution of ethionamide and Lowenstein- Jensen (LJ) media incorporated with ethionamide were 
preincubated at 4°C and 37°C prior to DST methods was incubated till 4 weeks at different temperatures and utilized 
for DST in MGIT 960. 
Results: Degradation of ethionamide working solution was observed at 37°C after 3 weeks of incubation. Ethionamide 
incorporated LJ media can be stored without compromise on susceptibility up to 5 weeks. But, a week of prior incuba-
tion at 37°C has deleterious effect on the DST profile. Ethionamide was found to degrade at 37°C after different time 
points when stored as solution or as LJ media. 
Conclusion: Use of DST formats that provide results within 2 weeks can be recommended for ethionamide susceptibil-
ity testing. J Microbiol Infect Dis 2013; 3(3): 128-132
Key words: Degradation; Ethionamide; LJ medium; MGIT 960; Mycobacterium tuberculosis.
Ethionamide depolama sıcaklığının duyarlılık testine etkisi
ÖZET 
Amaç: Ethionamide ısıya duyarlı yapısı nedeniyle, ilaç duyarlılık testinde (DST) ısının etkisini ve sıvı veya katı ortamdaki 
dayanıklılık durumunun araştırılması amaçlanmıştır. Yöntemler: Ethionamide çalışma solüsyonu ve Lowenstein-Jensen 
(LJ) besiyeri hazırlanarak 4°C ve 37°C bekletildi ve ardından DST yöntemiyle 4 haftaya kadar MGIT 960 besiyeri ile test 
edildi. 
Bulgular: Ethionamide çalışma solusyonunda 37°C’de 3 haftalık inkübasyonun ardından bozunma olduğu gözlenmiştir. 
Ethionamide LJ ortamında beş haftaya kadar etkinliğinde bozulma olmadan saklanabilir. Fakat 37°C de bir hafta daha 
bekletilmesi ilaç duyarlılık profiline zararlı etkili olabilir. Ethionamide 37°C bekletilmesiyle farklı zaman aralıklarında sıvı 
ya da LJ ortamında bekletilmesiyle etkinliğinde değişmeler olduğu saptandı. 
Sonuç: DST ortamında ethionamide için iki haftaya kadar olan testlerin değerlendirilmesi önerilir. 
Anahtar kelimeler: Bozunma, Etionamide, LJ besiyeri, MGIT 960, Mycobacterium tuberculosis
INTRODUCTION
Ethionamide (ETH) though used in the treatment of 
multi drug resistant tuberculosis (MDR-TB) patients 
in the country for more than a decade; ambiguity in 
laboratory susceptibility results stills remains.1 Drug 
susceptibility testing (DST) for ETH pose a chal-
lenge as there arises inconsistency between testing 
formats for reasons unclear; mode of action, inter-
pretation of resistance and potency of drug in the 
medium.2 Potency of the drug is a measure of purity 
of the drug in a formulation or in the complex used 
to stabilize the drug.3 On the other hand; potency 
also indicates effectiveness of the drug during test-
ing procedures. If potency of the drug is maintained 
till completion of the test, the interpretation is con-
sidered valid and reproducible.4 Effort is underway 
to understand probable reasons for discrepancy 
within phenotypic testing methods. Several studies 
have dealt upon degradation of anti-tuberculosis 
drugs.5-7 Several anti-tuberculosis drugs except ka-Lakshmi R, et al. Stability of ethionamide during DST procedures 129
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namycin and capreomycin was found to deteriorate 
even as early as 1 week and ethionamide after 2 
weeks of incubation at 37°C.8 Degradation of drugs 
during combined therapy was reported especially in 
rifampicin when used with isoniazid. Isoniazid acts 
as catalyst triggering the degradation of rifampicin 
in acidic medium.5 Recovery of drug was also mea-
sured when mixed with food and juices in order to 
assess the effect of food components in maintaining 
stability of the drug.7 Loss in potency was indicated 
in the data sheet of certain drugs such as strepto-
mycin dihydro-sulfate wherein around 50% loss is 
observed with varying pH and temperature. But the 
drug as solution is stable when stored at -20°C for 
more than a year.9 Therefore, effect of temperature 
on storage of ethionamide in solution and in com-
bination with egg based solid Lowenstein- Jensen 
(LJ) media and was undertaken to determine a 
probable cause for discrepancy between suscepti-
bility testing formats.
METHODS
Effect of temperature on ethionamide used in 
liquid culture systems (MGIT960)
Stock concentration of 10,000µg/ml of ethionamide 
drug was prepared by dissolving 10mg of ETH pow-
der (Sigma, USA) in 10ml of triethylene glycol (Mer-
ck). Working concentrations (2.5, 5.0, 7.5 and 10µg/
ml) were prepared from stock by diluting with sterile 
distilled water. One microliter aliquots of each con-
centration were stored at -80°C, 4°C and 37°C for a 
maximum of 4 weeks and tested once weekly. Drug 
susceptibility testing was performed weekly once in 
MGIT 960 system following manufacturer’s instruc-
tions for 5 strains inclusive of H37Rv, 3 strains sensi-
tive and one strain resistant to ETH.10 Susceptibility 
results were recorded once the instrument provided 
a printed report. To minimize clonal variation, strains 
used in the experiment were sub cultured from pri-
mary MGIT 960 positive tube into fresh tube and 
used weekly.
Effect of temperature on ethionamide drug used 
in solid LJ media
Drug susceptibility testing of Mycobacterium tuber-
culosis isolates for ETH was performed according 
to standard procedure.11-12 Strains used in MGIT 
960 were used in solid LJ medium. Strains were 
sub-cultured from original slope and one slope of 
each strain was tested every week for DST. Drug 
media at the specified concentrations of ETH were 
prepared in a single lot to restrict batch variation. 
Prepared media was pre-incubated at two different 
temperatures viz. 4°C and 37°C for a minimum of 1 
week to a maximum of 6 weeks before performing 
DST procedures. Susceptibility testing was done 
once weekly by proportion sensitivity testing (PST) 
and conventional minimum inhibitory concentration 
(MIC) methods.
Conventional MIC method was performed us-
ing 4mg moist weight of culture, whereas for PST 
method, 1 mg of culture with three serial decreasing 
1 in 10 fold dilutions were used. Briefly, one- third 
loopful of 2-3 weeks old culture on LJ media was 
suspended in 1ml of sterile distilled water and vor-
texed to obtain an even suspension. Coarse par-
ticles or clumps in the suspension were allowed to 
settle at room temperature. Ten microliters of the 
suspension was inoculated onto drug containing 
and drug free LJ medium. Concentrations of ETH 
viz. 20, 28.5, 40, 57, 80, 114 as in the conventional 
procedure and an additional concentration of 156 
µg/ml were used. Tenfold dilutions from 1 mg/ml 
concentration were prepared by adding 0.2 ml to 
1.8 ml sterile distilled water (S1, 10-1). Two further 
serial dilutions 10-2 (S2) and 10-3 (S3) were pre-
pared in the similar manner. Ten microliters from the 
above dilutions were inoculated onto drug free and 
drug containing (at 40ug/ml of ETH) media. Results 
were read after 28 days and 42 days of incubation 
at 37°C for MIC and PST methods respectively. 
Interpretation of conventional MIC method: Iso-
lates with ≥20 colony counts (1+ grading) were con-
sidered resistant to particular drug concentration of 
ETH. Break point MIC value for defining resistance 
in conventional MIC method presently used was 
≥114 µg/ml and value less than that was considered 
susceptible. 
Interpretation of PST method: World Health Or-
ganization (WHO) recommended concentration of 
40 µg/ml was used for ETH in PST method. Isolates 
with more than 1% of colony forming units in drug 
containing LJ slopes in comparison with drug free 
LJ slopes were considered as resistant. Isolates 
with values less than 1% criteria defining resistance 
were considered as susceptible. As a modification, 
we considered isolates with PST values between 
0.9% and 1.1% as “borderline”.
RESULTS
Effect of temperature on ethionamide drug used 
in liquid culture systems (MGIT960)
Results of the study indicated that there is no 
marked difference in susceptibility patterns of the 
strains tested using ETH stored under -80°C and 
4°C (Table 1). There was no interchange between 
the resistant or susceptibility pattern among the Lakshmi R, et al. Stability of ethionamide during DST procedures 130
J Microbiol Infect Dis   www.jmidonline.org   Vol 3, No 3, September 2013
strains though the drug was stored for 4 weeks at 
the specified temperature. To contrast, when ETH 
stored at 37°C was used for susceptibility testing, 
no appreciable change in pattern was observed 
until week 3. When pre-incubated (at 37°C for 4 
weeks) drug was used, strains that were classified 
as susceptible to ETH demonstrated resistant phe-
notype. The single strain that remained susceptible 
in MGIT 960 till the end time point showed similar 
profile in DST by MIC and PST methods on LJ me-
dium. However, difference in susceptibility was not 
noted among resistant strains at both incubation 
temperatures.
Table 1. Effect of temperature on ethionamide (ETH) drug 
used in liquid culture systems (MGIT960)
Strain / ETH
Susceptibility
Pattern
Weeks
Susceptibility results
 obtained for ETH
 pre- incubated at 
specified temperatures
-80°C 4°C 37°C
H37Rv /
standard
susceptible
strain
Wk1 Sens Sens Sens
Wk2 Sens Sens Sens
Wk3 Sens Sens Sens
Wk4 Sens Sens Res
Strain1 /
susceptible
Wk1 Sens Sens Sens
Wk2 Sens Sens Sens
Wk3 Sens Sens Sens
Wk4 Sens Sens Sens
Strain 2 /
susceptible
Wk1 Sens Sens Sens
Wk2 Sens Sens Sens
Wk3 Sens Sens Sens
Wk4 Sens Sens Res
Strain 3 /
susceptible
Wk1 Sens Sens Sens
Wk2 Sens Sens Sens
Wk3 Sens Sens Sens
Wk4 Sens Sens Res
Strain 4 /
Resistant
Wk1 Res Res Res
Wk2 Res Res Res
Wk3 Res Res Res
Wk4 Res Res Res
Sens – Sensitive; Res – Resistant; Wk- Week
Effect of temperature (4°C) on ethionamide used 
in solid culture
Solid LJ media containing ETH can be stored up 
to 4 weeks and conventional MIC method can be 
performed without any variation in susceptibility 
pattern of the strains (Table 1). H37Rv and sensitive 
strains showed susceptible phenotype till 4 weeks 
of incubation at 4°C. Resistant strains showed re-
sistant phenotype throughout the time period and 
also served as control for the experiment. Of the 3 
susceptible strains, 2 remained the same when LJ 
media incubated till 6 weeks was used. The single 
sensitive strain and H37Rv exhibited resistance after 
4 weeks of incubation.
Table 2. Susceptibility results for ETH using LJ media 
stored at different temperatures
Strain / ETH
Susceptibility
Pattern
Weeks
37°C 4°C
MIC
(μg/ml)
PST
(40 μg/ml)
MIC
(μg/ml)
PST
(40 μg/
ml)
H37Rv /
standard
susceptible
strain
Wk1 80 0 40 0
Wk2 156 20 57 0
Wk3 156 100 40 0
Wk4 >156 25 57 0
Wk5 >156 100 114 22
Wk6 >156 25 80 25
Strain1 /
susceptible
Wk1 114 6.6 80 0
Wk2 156 10 <20 0
Wk3 >156 66.6 57 2.3#
Wk4 >156. 13.5 40 0
Wk5 >156 17 80 0
Wk6 >156 192 80 11.7
Strain 2 /
susceptible
Wk1 57 1.3 28.5 0
Wk2 156 350 40 2*
Wk3 >156 50 40 1.11*
Wk4 >156 137.5 57 3.3*
Wk5 >156 93.7 40 0
Wk6 >156 41.6 57 0.4
Strain 3 /
susceptible
Wk1 40 0 28.5 0
Wk2 80 297 28.5 0
Wk3 >156 46.1 <20 0
Wk4 >156 171.4 28.5 0
Wk5 >156 140 28.5 2.5
Wk6 >156 47 40 1
Strain 4 /
resistant
Wk1 >156 133 >156 133
Wk2 >156 116 >156 71.4
Wk3 >156 83.3 >156 25
Wk4 >156 20 >156 83.3
Wk5 >156 13.3 >156 140
Wk6 >156 112 >156 85
ETH=ethionamide; MIC=minimum inhibitory concentra-
tion method- represented as the drug concentration that 
inhibited 99% of the bacteria; PST=proportion sensitivity 
testing method- represented at the percentage of propor-
tion of bacteria resistant to the drug tested at their criti-
cal concentration determining resistance. The strain is Lakshmi R, et al. Stability of ethionamide during DST procedures 131
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considered resistant if the proportion percentage is more 
than the defined criteria i.e., 1% for ETH at 40 μg/ml; 
Wk=week;  #=Smooth morphology was observed; *=un-
explained phenomenon, could possibly due to technical 
fault.
Referring to PST method, media can be stored 
effectively for a maximum of upto 5 weeks as there 
was no change in susceptibility pattern of strains 
tested. Resistant strain remained resistant through-
out the testing period. Susceptible strains showed 
sensitive phenotype till week 4 but indicated resis-
tant phenotype at week 5. One of the three suscep-
tible strains remained sensitive till week 5.
Effect of temperature (37°C) on ethionamide 
drug used in solid culture
Ethionamide drug media can be stored for one week 
at 37°C without any compromise on the suscepti-
bility pattern of the drug in MIC and PST methods. 
Change in drug susceptibility pattern was observed 
in media stored for two weeks in all the strains 
tested except a single susceptible strain that exhib-
ited sensitive phenotype. Resistant strains had no 
change in their phenotype during entire time point. 
Of the four susceptible strains, two were resistant 
and two were susceptible by MIC method. Labora-
tory standard strain H37Rv showed borderline resis-
tance as the numbers of CFUs were just more than 
the criteria fixed. But in PST it was depicted as sus-
ceptible. Therefore, the inconsistency may probably 
due to effect of higher inoculum used in MIC method 
than in PST method (Table 2).
DISCUSSION
Ethionamide is a thermolabile drug. Hence, it is ad-
vised to use drug incorporated media judiciously as 
soon as it is prepared and storage might deteriorate 
the drug activity.13 Ethionamide has been indicated 
to exhibit cross resistance with isoniazid.14-16 There-
fore, reliability of the ETH susceptibility testing is 
the need of the hour. Ability of the drug to maintain 
its potency till completion of the test is essential for 
precise interpretation of susceptibility.3,4 Major impli-
cations can be deduced from the present study. Pri-
marily, the role of temperature as one of the major 
defining factor in susceptibility testing and its effect 
on the drug as well as on drug incorporated media 
was studied. Another is the stability of the drug dur-
ing the testing procedures.
Present study gains importance as it attempts 
to understand the reasons for uncertainty in phe-
notypic tests employed for ethionamide. Role of 
drug deterioration during the testing procedures as 
a cause for such discrepancies was determined. 
Earlier report on the stability of ethionamide was 
based on agar based medium.8 This is probably the 
first study on stability of ethionamide in LJ medium 
which is preferably used in resource limited set-
ting and in automated liquid culture systems such 
as MGIT 960. Stability in MGIT 960 was assessed 
because the cut off MIC is much below the thera-
peutic index of the drug and reliable results can be 
obtained for the drug (data not shown). Interpreta-
tion of degradation can be monitored easily by us-
ing the standardized method routinely followed in 
the laboratory. Morphology of the colony was used 
earlier to grade degradation.8 Therefore, shift in MIC 
values and susceptibility pattern was considered as 
a marker for drug degradation.
In accordance with previous report, loss of 
drug activity was found negligible as there was 
no change/ shift in the susceptibility pattern of the 
strains at -80°C and 4°C till one month of incuba-
tion whereas it was found to degrade after 3 weeks 
upon incubation at 37°C.8 This was supported by 
susceptibility profile of the panel strains where in 
resistant phenotype was observed at 37°C after 
3 weeks in known susceptible strains except one 
strain that remained susceptible till the end. This 
strain unlike the other susceptible strains in the 
panel could have had more number of susceptible 
population that are well below the therapeutic index 
of the drug and least number of borderline and/ re-
sistant clones that lead to erroneous results. The 
present study reiterates the fact put forth by Griffith 
and Bodily that ethionamide degrades at 37°C and 
the same has deleterious effect on susceptibility 
pattern of the strains.8 One more advantage is the 
use of automated (MGIT 960) method employed 
to assess effect of temperature on the drug. Prob-
lem of drug degradation does not affect the results 
obtained in MGIT 960 as the entire susceptibil-
ity testing algorithm is completed within 13 days.10 
Hence results obtained are due to the degradation 
of drug owing to prior incubation and not because 
of the adverse exposure during DST procedures. It 
is therefore recommended to use the drug if stored 
for more than 3-7°C within a week to obtain reliable 
results. There is a chance for loss of activity in drug 
incorporated media during conventional MIC and 
PST procedures that warrant 4-6 weeks of incuba-
tion at 37°C before interpretation.
Another approach was to determine the sta-
bility of ethionamide in solid LJ medium. This was 
performed to understand whether the discrepancy 
in ETH susceptibility is due to degradation of drug 
in medium. Use of long term stored media in DST Lakshmi R, et al. Stability of ethionamide during DST procedures 132
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procedures may induce false resistance due to 
degradation of drugs.4 The results indicates that till 
one month the media can be stored and used (if 
required) without shift in the susceptibility pattern.
As expected, storage at 37°C even after one 
week induces major change in the susceptibility 
pattern. It was evidenced by shift in MIC value for 
clinical and laboratory susceptible strains. Even one 
week prior incubation at 37°C had deleterious ef-
fect on the pattern. It is also possible that due to 
loss of activity of ETH the persistors might indicate 
a false resistance. Observation made from these 
results implies that there is deterioration of the drug 
after 5 weeks of incubation at 37°C; i.e., 1 week pre-
incubation and 4 weeks incubation for MIC method. 
Finalization of conventional MIC is performed after 
4 weeks of incubation. Hence, there is no issue of 
drug deterioration during this time point, but prob-
lem of drug deterioration arises in PST method 
where finalization of the results is performed after 
6 weeks of incubation. Therefore, it can be inferred 
that conventional MIC method can be considered 
for ethionamide DST, but there may be discrepancy 
in PST method. Thus, any strain with susceptible 
phenotype in PST can be considered true suscep-
tible, but if resistant, there can be chances of false 
resistance due to inactivation of the drug due to pro-
longed incubation. These results provide additional 
support / indication for previous observation and 
hypothesis stated by Mitchison that MIC method is 
better than PST method in susceptibility testing pro-
cedures.17
Advantages of the study are: the use of routine-
ly employed LJ medium, automated liquid culture 
system MGIT 960 for assessing activity of the drug 
and use of M. tuberculosis strains resistant and sus-
ceptible to ethionamide. Zone of inhibition or verti-
cal diffusion studies not very useful in quantitatively 
determining the loss of drug activity.8 One limitation 
is that validation by quantitative measurement of 
loss of drug activity by spectrophotometric method. 
Binding of ethionamide to egg proteins could not be 
ruled out as a factor for inconsistency in DST proce-
dures employing LJ medium until confirmed.18
To conclude, results of both broth cultures and 
solid culture indicate that it is recommended to store 
the drug as solution or as media at 4°C for maxi-
mum of 1 month prior to use. Effect of temperature 
on loss of drug activity/degradation during incuba-
tion needs to be further confirmed with analytical 
methodology. Susceptibility procedures using liquid 
culture formats like MGIT 960 and LRP assay that 
delivers results with in two weeks’ time are probably 
ideal and reliable for ethionamide.
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